Yüklüyor......
Comparison of the Prognostic and Predictive Utilities of the 21-Gene Recurrence Score Assay and Adjuvant! for Women with Node-Negative, ER-Positive Breast Cancer: Results from NSABP B-14 and NSABP B-20
The Oncotype DX(®) Recurrence Score(®) (RS) is a validated genomic predictor of outcome and response to adjuvant chemotherapy in ER-positive breast cancer. Adjuvant! was developed using SEER registry data and results from the Early Breast Cancer Clinical Trialists’ overview analyses to estimate outc...
Kaydedildi:
| Yayımlandı: | Breast Cancer Res Treat |
|---|---|
| Asıl Yazarlar: | , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2011
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4266581/ https://ncbi.nlm.nih.gov/pubmed/21221771 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-010-1331-z |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|